Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 13.57 is 31% above its 5-year average of 10.37, near the high end of its 5-year range (4.19–16.18).
As of the fiscal period ended Tuesday, June 30, 2026. 26.80% above its 12-month average of 10.70.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 13.57.
CURRENT RATIO
13.57
CURRENT RATIO AVG TTM
10.70
CURRENT RATIO AVG 3Y
9.23
CURRENT RATIO AVG 5Y
10.37
CURRENT RATIO AVG 10Y
7.40
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+26.80%
CURRENT VS 3Y AVG
+47.01%
CURRENT VS 5Y AVG
+30.94%
CURRENT VS 10Y AVG
+83.33%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.05
median of 417 covered companies
CURRENT VS SECTOR MEDIAN
+345.01%
vs the sector median at left
Cogent Biosciences, Inc.
Market Cap
$5.27B
Current Ratio
13.57
TTM Avg
10.70
3Y Avg
9.23
5Y Avg
10.37
Market Cap
$5.20B
Current Ratio
4.20
TTM Avg
4.30
3Y Avg
4.12
5Y Avg
3.47
Market Cap
$5.20B
Current Ratio
7.02
TTM Avg
8.28
3Y Avg
8.59
5Y Avg
7.77
Market Cap
$5.53B
Current Ratio
17.85
TTM Avg
17.70
3Y Avg
17.06
5Y Avg
17.77
Market Cap
$4.92B
Current Ratio
26.10
TTM Avg
14.27
3Y Avg
14.23
5Y Avg
14.47
Market Cap
$4.81B
Current Ratio
6.95
TTM Avg
6.77
3Y Avg
6.23
5Y Avg
10.87
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | $5.27B | 13.57 | 10.70 | 9.23 | 10.37 |
| Doximity, Inc. (DOCS)vs › | $5.35B | 6.08 | 6.53 | 6.56 | 6.07 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 4.20 | 4.30 | 4.12 | 3.47 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | 7.02 | 8.28 | 8.59 | 7.77 |
| Erasca, Inc. (ERAS)vs › | $5.11B | 8.29 | 9.94 | 10.32 | 11.01 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.53B | 17.85 | 17.70 | 17.06 | 17.77 |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 11.69 | 9.86 | 7.15 | 7.15 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.92B | 26.10 | 14.27 | 14.23 | 14.47 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | 6.95 | 6.77 | 6.23 | 10.87 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.78B | 4.79 | 3.12 | 4.00 | 4.41 |
Current Ratio
13.57
Quick Ratio
13.57
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 13.57 |
| 2026-03-31 | 15.14 |
| 2025-12-31 | 14.23 |
| 2025-09-30 | 6.38 |
| 2025-06-30 | 4.19 |
| 2025-03-31 | 5.13 |
| 2024-12-31 | 5.32 |
| 2024-09-30 | 6.44 |
| 2024-06-30 | 9.25 |
| 2024-03-31 | 12.05 |
| 2023-12-31 | 7.09 |
| 2023-09-30 | 8.24 |
| 2023-06-30 | 12.99 |
| 2023-03-31 | 10.71 |
| 2022-12-31 | 9.87 |
| 2022-09-30 | 12.59 |
| 2022-06-30 | 11.96 |
| 2022-03-31 | 10.89 |
| 2021-12-31 | 13.04 |
| 2021-09-30 | 12.42 |
| 2021-06-30 | 16.18 |
| 2021-03-31 | 28.16 |
| 2020-12-31 | 18.70 |
| 2020-09-30 | 6.63 |
| 2020-06-30 | 2.90 |
| 2020-03-31 | 3.37 |
| 2019-12-31 | 3.06 |
| 2019-09-30 | 1.88 |
| 2019-06-30 | 2.41 |
| 2019-03-31 | 2.65 |
| 2018-12-31 | 3.25 |
| 2018-09-30 | 3.39 |
| 2018-06-30 | 3.91 |
| 2018-03-31 | 1.53 |
| 2017-12-31 | 3.79 |
| 2017-09-30 | 4.69 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
| 2016-09-30 | 1.48 |
| 2015-09-30 | 0.00 |
